Shield your portfolio from market swings with low-beta picks like VIPS, GDS, FUTU and VRNA, each showing strong momentum.

Insiders who bought Cardiff Oncology, Inc. (NASDAQ:CRDF) stock lover the last 12 months are probably not as affected by last week’s 12% loss. Even after accounting for the recent loss, the US$1.01m ...